angiotensin ii has been researched along with Hypertrophy, Right Ventricular in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, Z; Ge, R; Jin, G; Li, Z; Lu, D; Ma, L; Nan, X; Su, S | 1 |
| Fried, ND; Gardner, JD; Gilpin, NW; Lazartigues, E; Lobell, TD; Morris, TM; Oakes, JM; Pearson, CS; Xu, J; Yue, X | 1 |
| Cavasin, MA; Demos-Davies, KM; Ferguson, BS; Hu, T; Keyse, SM; Kidger, AM; Lane, RH; McKinsey, TA; McKnight, RA; Nozik, ES; Robinson, EL; Rubino, M; Stratton, MS; Weiser-Evans, MCM; Wennersten, SA | 1 |
| Li, G; Li, X; Li, Z; Liu, A; Liu, Y; Su, J; Sun, L; Xu, Y; Zhu, Y | 1 |
| Caliari, MV; Campagnole-Santos, MJ; Cara, DC; Cardoso, JA; Kangussu, LM; Lautner, RQ; Magalhães, GS; Marques, FD; Murari, A; Noviello, ML; Oliveira, ML; Pereira, JM; Rodrigues-Machado, MG; Santos, RA | 1 |
| Calderone, A; Chabot, A; Dupuis, J; El Khoury, N; Fiset, C; Hertig, V; Jasmin, JF; Meus, MA; Nattel, S; Naud, P; Villeneuve, L | 1 |
| Bruce, E; Espejo, A; Francis, J; Horowitz, A; Katovich, MJ; Nair, A; Oswalt, A; Raizada, MK; Rathinasabapathy, A; Shenoy, V; Steckelings, UM; Sumners, C; Unger, T | 1 |
| Chichger, H; Choudhary, G; Harrington, EO; Mende, U; O'Connell, KA; Vang, A; Zhang, P | 1 |
| Aiello, EA; Caldiz, CI; Chiappe de Cingolani, G; Cingolani, HE; Correa, MV; Dulce, RA; Ennis, IL; Garciarena, CD; Nolly, MB; Perez, NG; Villa-Abrille, MC; Yeves, AM | 1 |
| Chen, BY; Chen, JK; Feng, HS; Huang, XJ; Liu, LB; Qu, P; Tie, R; Yu, J; Zhao, YF; Zhu, MZ; Zhu, XX | 1 |
| Barrick, CJ; Caron, KM; Dackor, RT; Lenhart, PM; Nagle, E | 1 |
| Bertolozzi, I; Boddi, M; Cecioni, I; Gensini, GF; Lumachi, C; Modesti, PA; Perna, AM; Vanni, S | 1 |
| Jin, D; Katayama, H; Kishi, K; Miyazaki, M; Muramatsu, M; Takai, S; Tamai, H | 1 |
| Feng, N; Hoover, DB; Paolocci, N | 1 |
| Morrell, NW; Morris, KG; Stenmark, KR | 1 |
| Barnes, M; Buckley, JM; Carabello, BA; Conrad, CC; Cooper, G; DeFreyte, G; Dell'Italia, LJ; Koide, M; Tomanek, RJ; Wei, CC; Zile, MR | 1 |
| Frasch, HF; Marshall, BE; Marshall, C | 1 |
| Brunner, F | 1 |
| Brunner, HR; Gabbiani, G; Mazzolai, L; Nicoud, F; Nussberger, J; Pedrazzini, T | 1 |
| Adams, MA; Friberg, P; Isgaard, J; Wåhlander, A; Wickman, A | 1 |
| Angelini, A; Battista Ambrosio, G; Dalla Libera, L; Ravara, B; Rossini, K; Sandri, M; Thiene, G; Vescovo, G | 1 |
| Belus, A; Bonnet, S; Hyvelin, JM; Marthan, R; Roux, E; Savineau, JP | 1 |
| Angelini, A; Betto, R; Dalla Libera, L; Ravara, B; Renken, C; Sabbadini, R; Sandri, M; Vescovo, G | 1 |
1 review(s) available for angiotensin ii and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Early signals after stretch leading to cardiac hypertrophy. Key role of NHE-1.
Topics: Adult; Angiotensin II; Biomechanical Phenomena; Cardiomegaly; Heart Ventricles; Humans; Hypertrophy, Right Ventricular; Obesity; Pressoreceptors; Reactive Oxygen Species; Signal Transduction; Sodium-Hydrogen Exchangers; Ventricular Function | 2008 |
22 other study(ies) available for angiotensin ii and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Hypertrophy, Right Ventricular; Hypoxia; Male; Medicine, Tibetan Traditional; Peptide Fragments; Peptidyl-Dipeptidase A; Plant Preparations; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Ventricular Remodeling | 2020 |
Effects of Chronic Nicotine Inhalation on Systemic and Pulmonary Blood Pressure and Right Ventricular Remodeling in Mice.
Topics: Administration, Inhalation; Angiotensin II; Animals; Atmosphere Exposure Chambers; Blood Pressure; Cardiac Catheterization; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Mice; Mice, Inbred C57BL; Nicotine; Pulmonary Artery; Vascular Remodeling; Vascular Resistance; Ventricular Remodeling | 2020 |
DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy.
Topics: Angiotensin II; Animals; Case-Control Studies; Cell Proliferation; Cells, Cultured; Dual-Specificity Phosphatases; Heart Ventricles; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; MAP Kinase Signaling System; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pulmonary Artery; Vascular Remodeling; Vasoconstrictor Agents | 2021 |
ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Arterial Pressure; Cytoprotection; Disease Models, Animal; Endothelium, Vascular; Enzyme Activation; Enzyme Activators; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Naphthalenes; Neointima; Peptide Fragments; Peptidyl-Dipeptidase A; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Resorcinols; Severity of Illness Index; Time Factors; Vasodilation | 2013 |
AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma.
Topics: Airway Remodeling; Angiotensin I; Angiotensin II; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Chronic Disease; Cytokines; Disease Models, Animal; Hypertrophy, Right Ventricular; Imidazoles; Lung; Male; Mice; Mice, Inbred BALB C; Molecular Mimicry; Ovalbumin; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Artery; Pulmonary Veins; Receptors, G-Protein-Coupled; Time Factors | 2013 |
Nestin is a marker of lung remodeling secondary to myocardial infarction and type I diabetes in the rat.
Topics: Actins; Airway Remodeling; Angiotensin II; Animals; Biomarkers; Cell Differentiation; Collagen Type I; Diabetes Mellitus, Type 1; Fibroblasts; Heart Failure; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; MicroRNAs; Myocardial Contraction; Myocardial Infarction; Nestin; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin; Transforming Growth Factor beta | 2015 |
Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cardiovascular Agents; Disease Models, Animal; Fibrosis; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Imidazoles; Lung; Male; Monocrotaline; Myocardium; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Fibrosis; Pyridines; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Signal Transduction; Vascular Remodeling; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling | 2015 |
PKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension.
Topics: Angiotensin II; Animals; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Collagen; Enzyme Activation; Fibroblasts; Fibrosis; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; p38 Mitogen-Activated Protein Kinases; Protein Kinase C beta; Protein Kinase C-delta; Rats, Sprague-Dawley; Ventricular Dysfunction, Right | 2015 |
Protective effects of vasonatrin peptide against hypobaric hypoxia-induced pulmonary hypertension in rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Atmospheric Pressure; Atrial Natriuretic Factor; Disease Models, Animal; Endothelin-1; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor | 2010 |
Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Diseases; Disease Models, Animal; Female; Gene Expression; Gene Expression Profiling; Gene Knockout Techniques; Genetic Association Studies; Heart Failure; Hypertension; Hypertrophy, Right Ventricular; Kidney Diseases; Male; Mice; Mice, Knockout; Phenotype; Proto-Oncogene Proteins c-akt; Receptor Activity-Modifying Protein 3; Renin; Sex Factors | 2012 |
Different growth factor activation in the right and left ventricles in experimental volume overload.
Topics: Adaptation, Physiological; Angiotensin II; Animals; Cardiac Volume; Collagen; Endothelin-1; Female; Growth Substances; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Insulin-Like Growth Factor I; Male; RNA, Messenger; Swine | 2004 |
Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Proliferation; Chymases; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Peptidyl-Dipeptidase A; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Serine Endopeptidases; Tetrazoles; Tunica Media | 2006 |
Forever young?: nerve growth factor, sympathetic fibers, and right ventricle pressure overload.
Topics: Adrenergic Fibers; Angiotensin II; Animals; Calcium; Endothelin-1; Heart Failure; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Mice; Nerve Growth Factor; Rats; Tyrosine 3-Monooxygenase; Vasoconstriction; Ventricular Dysfunction, Right | 2007 |
Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Heart; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Peptidyl-Dipeptidase A; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1995 |
Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cats; Constriction, Pathologic; Elasticity; Heart; Hemodynamics; Hypertension; Hypertrophy, Right Ventricular; Losartan; Myocardial Contraction; Myocardium; Pulmonary Artery; Renin-Angiotensin System | 1999 |
Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
Topics: Angiotensin II; Animals; Drug Combinations; Endothelin-1; Endothelins; Enzyme Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; In Vitro Techniques; Lung; Male; Monocrotaline; Oligopeptides; omega-N-Methylarginine; Peptides, Cyclic; Piperidines; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1999 |
Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat.
Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Endothelin-1; Endothelins; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Monocrotaline; Myocardium; Perfusion; Poisons; Protein Precursors; Rats; Rats, Sprague-Dawley | 1999 |
Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice.
Topics: Angiotensin II; Animals; Blood Pressure; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Mice; Myocardium | 2000 |
Inhibited expression of insulin-like growth factor I mRNA and attenuated cardiac hypertrophy in volume overloaded hearts treated with difluoromethylornithine.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Disease Models, Animal; Eflornithine; Gene Expression Regulation; Hypertrophy, Right Ventricular; Insulin-Like Growth Factor I; Male; Organ Size; Ornithine Decarboxylase Inhibitors; Rats; Rats, Wistar; RNA, Messenger | 1998 |
Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Biphenyl Compounds; Calcium Channel Blockers; Drug Evaluation, Preclinical; Gene Expression Regulation; Heart Failure; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Infusion Pumps, Implantable; Irbesartan; Male; Monocrotaline; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Nifedipine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Tumor Necrosis Factor-alpha | 2001 |
Effect of chronic hypoxia on agonist-induced tone and calcium signaling in rat pulmonary artery.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Caffeine; Calcium; Calcium Signaling; Chronic Disease; Endothelin-1; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; In Vitro Techniques; Indoles; Intracellular Membranes; Male; Muscle, Smooth, Vascular; Pulmonary Artery; Rats; Rats, Wistar; Reference Values; Vasoconstriction; Vasodilator Agents; Vasomotor System | 2001 |
Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine.
Topics: Angiotensin II; Animals; Apoptosis; Blotting, Western; Cells, Cultured; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Heart Failure; Heart Ventricles; Hypertrophy, Right Ventricular; In Situ Nick-End Labeling; Male; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Sphingosine; Tumor Necrosis Factor-alpha | 2001 |